Dimerix (ASX:DXB) did it again
ASX-listed kidney disease drug developer Dimerix (ASX: DXB) is well positioned to bring its DMX-200 drug to market for Focal Segmental Glomerulosclerosis (FSGS). The drug is in a Phase 3 trial, which has shown solid interim results. The company secured its inaugural license deal in October 2023 with Advanz Pharma,…
5 ASX Health Stocks
Stuart Roberts from Stocks Down Under discussed the potential promise of biotech, sharing his perspectives about the industry's future amidst changing interest rates. He compares the current market situation to 1994 when the introduction of interest rate tightenings led to bear markets for many pre-revenue stocks. However, despite ongoing mildly bearish…
Should you buy Rio Tinto shares? This is one of the most asked questions by investors, given how prominent a company it is. It is only behind CBA (ASX:CBA) and BHP (ASX:BHP), sitting at a market capitalisation of ~$160bn as of mid-March 2024.
The first few months of 2024 have been tough for Rio Tinto (ASX:RIO).…
ASX gold stocks should be in focus right now!
Our own Stuart Roberts identifies the ongoing merit of investing in gold, seeing it as an effective insurance policy against global instability. Stuart suggests setting aside about 10% of your assets in ASX gold stocks. However, he recognises a generational shift towards investments in Bitcoin and…
Where will gold prices go? It is a question investors are asking all the time, but particularly in recent years given that global geopolitical instability and macroeconomic turbulence are its two best mates. But where to now from here? Will investors buying gold end up buying high and selling low, or will they still reap…
In this article, we'll look to answer the question: Should I buy Qantas shares?
Qantas (ASX:QAN) has recorded significant windfall from the post-COVID travel recovery and demand remains strong. However, it has not gone through the period unscathed, with reputational issues resulting in Alan Joyce departing after 15 years. Investors have the promise of profitable non-stop…
Investing in ASX coal stocks in 2024 is not at all vogue or woke, but could it be moneymaking? Not if you believe coal is on the way out in the medium term, but it could still be money-making in the short-term, and perhaps even beyond.
Look at how earlier this month, the Queensland Government granted…
The NVIDIA share price in 2024 ... what's in store?
NVIDIA reported stunning quarterly numbers on 22 February 2024 with revenues beating analysts forecasts by a wide margin. Additionally, the outlook for the current quarter was better than expected as well! The share price jumped by 10% in after hours trading on Wall Street almost…
Investors should seriously look into Australian uranium stocks. And we're not just talking all ASX stocks involved in yellowcake, we're talking about those with projects in Australia.
The uranium pricing upswing is good news for all stocks...
Uranium is a unique commodity with an eclectic range of applications and it seems marketplaces across the globe are…
A2 Milk: The Comeback Kid
Stuart Roberts from Stocks Down Under presents an interesting view on A2 Milk (ASX:A2M), stating it as a potential stock comeback after a downfall that followed the China trade wars. Despite the reducing birth rates in China, he suggests A2 is still a preferred premium brand from the infant to…
